drugset / Trial / NCT01223742

Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy

NCT01223742 ↗

Summary

The aim of this study was to evaluate the effect of exogenous ALC on the both physical and mental fatigue in mild and moderate encephalopatic patients.

Timeline

Start
2002-06
Primary completion
—
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetylcarnitine Small molecule 2 g Oral